alexa Editor - Toshiyuki Ishiwata | Nippon Medical School | 2220
ISSN: 2157-2518

Journal of Carcinogenesis & Mutagenesis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Toshiyuki Ishiwata

Toshiyuki Ishiwata Toshiyuki Ishiwata
Associate Professor
Department of Pathology
Nippon Medical School
Japan
Biography

Dr. Ishiwata completed his MD degree from Kawasaki Medical School, Okayama Japan during 1986-1988.Then he completed  Internal Medicine residency from Kosei General Hospital Tokyo Japan in1988.He was  instructor of Pathology in Nippon Medical School,  Tokyo, Japan in 1994.Completed his  PhD from Nippon Medical School in1995.In 1998 he has done  Postdoctoral Research fellowship in the  Department of Medicine Biological Chemistry and Pharmacology at the University of California in Irvine USA under the guidance of  Prof. Murray Korc .In 2000,he was  Assistant Professor in Department of Pathology, Nippon Medical School.From 2004,he is Associate Professor Department of Pathology in Nippon Medical School.

Research Interest

Pancreatic Cancer,Cancer stem cells,Growth factor and growth factor receptors,Proteoglycan

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Pancreatic Ductal Adenocarcinoma: Basic and Clinical Challenges for Better Prognosis
Toshiyuki Ishiwata
Commentary: J Carcinog Mutagen 2013, S9- 005
DOI: 10.4172/2157-2518.S9-005
 
In Vivo Bioluminescence Imaging of Pancreatic Cancer Xenografts in NOG Mice
Hisashi Yoshimura, Yoko Matsuda, Zenya Naito and Toshiyuki Ishiwata
Research Article: J Carcinog Mutagen 2013, S9- 003
DOI: 10.4172/2157-2518.S9-003
 
The Roles and Molecular Mechanisms of Nestin Expression in Cancer with a Focus on Pancreatic Cancer
Yoko Matsuda, Hisashi Yoshimura, Zenya Naito and Toshiyuki Ishiwata
Review Article: J Carcinog Mutagen 2013, S9- 002
DOI: 10.4172/2157-2518.S9-002
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7